Ingevity Corp has a consensus price target of $61.33 based on the ratings of 6 analysts. The high is $92 issued by Loop Capital on March 24, 2023. The low is $45 issued by Wells Fargo on July 11, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, BMO Capital, and Loop Capital on July 11, 2024, May 8, 2024, and May 7, 2024, respectively. With an average price target of $52 between Wells Fargo, BMO Capital, and Loop Capital, there's an implied 17.01% upside for Ingevity Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/11/2024 | Buy Now | 1.26% | Wells Fargo | Michael Sison | $55 → $45 | Maintains | Equal-Weight | Get Alert |
05/08/2024 | Buy Now | 23.76% | BMO Capital | John McNulty | $50 → $55 | Maintains | Market Perform | Get Alert |
05/07/2024 | Buy Now | 26.01% | Loop Capital | Christopher Kapsch | $49 → $56 | Maintains | Hold | Get Alert |
05/02/2024 | Buy Now | 30.51% | Oppenheimer | Ian Zaffino | $50 → $58 | Maintains | Outperform | Get Alert |
04/22/2024 | Buy Now | 39.51% | Jefferies | Daniel Rizzo | $52 → $62 | Upgrade | Hold → Buy | Get Alert |
02/23/2024 | Buy Now | 12.51% | Wells Fargo | Michael Sison | $43 → $50 | Maintains | Equal-Weight | Get Alert |
11/09/2023 | Buy Now | -3.24% | BMO Capital | John McNulty | $54 → $43 | Maintains | Market Perform | Get Alert |
10/03/2023 | Buy Now | 19.26% | Loop Capital | Christopher Kapsch | $62 → $53 | Downgrade | Buy → Hold | Get Alert |
08/07/2023 | Buy Now | 35.01% | BMO Capital | John McNulty | $71 → $60 | Downgrade | Outperform → Market Perform | Get Alert |
07/27/2023 | Buy Now | — | Loop Capital | Christopher Kapsch | — | Upgrade | Hold → Buy | Get Alert |
05/23/2023 | Buy Now | 23.76% | Wells Fargo | Michael Sison | $66 → $55 | Maintains | Equal-Weight | Get Alert |
05/09/2023 | Buy Now | 80.02% | BMO Capital | John McNulty | $100 → $80 | Maintains | Outperform | Get Alert |
05/05/2023 | Buy Now | 48.51% | Wells Fargo | Michael Sison | $80 → $66 | Maintains | Equal-Weight | Get Alert |
05/05/2023 | Buy Now | 44.01% | Loop Capital | Christopher Kapsch | $92 → $64 | Downgrade | Buy → Hold | Get Alert |
04/17/2023 | Buy Now | 80.02% | Wells Fargo | Michael Sison | $85 → $80 | Maintains | Equal-Weight | Get Alert |
03/24/2023 | Buy Now | 107.02% | Loop Capital | Garik Shmois | $100 → $92 | Maintains | Buy | Get Alert |
03/01/2023 | Buy Now | 91.27% | Wells Fargo | Michael Sison | $76 → $85 | Maintains | Equal-Weight | Get Alert |
02/02/2023 | Buy Now | 125.02% | Loop Capital | Christopher Kapsch | $81 → $100 | Upgrade | Hold → Buy | Get Alert |
01/09/2023 | Buy Now | 71.02% | Wells Fargo | Michael Sison | $73 → $76 | Maintains | Equal-Weight | Get Alert |
11/04/2022 | Buy Now | 64.27% | Wells Fargo | Michael Sison | $67 → $73 | Maintains | Equal-Weight | Get Alert |
10/18/2022 | Buy Now | 50.77% | Wells Fargo | Michael Sison | $74 → $67 | Maintains | Equal-Weight | Get Alert |
10/11/2022 | Buy Now | 95.77% | BMO Capital | John McNulty | $89 → $87 | Maintains | Outperform | Get Alert |
05/09/2022 | Buy Now | 66.52% | Wells Fargo | Michael Sison | $70 → $74 | Maintains | Equal-Weight | Get Alert |
10/29/2021 | Buy Now | 89.02% | Wells Fargo | Michael Sison | — | Maintains | Equal-Weight | Get Alert |
07/29/2021 | Buy Now | 113.77% | Oppenheimer | Ian Zaffino | — | Maintains | Outperform | Get Alert |
The latest price target for Ingevity (NYSE:NGVT) was reported by Wells Fargo on July 11, 2024. The analyst firm set a price target for $45.00 expecting NGVT to rise to within 12 months (a possible 1.26% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Ingevity (NYSE:NGVT) was provided by Wells Fargo, and Ingevity maintained their equal-weight rating.
The last upgrade for Ingevity Corp happened on April 22, 2024 when Jefferies raised their price target to $62. Jefferies previously had a hold for Ingevity Corp.
The last downgrade for Ingevity Corp happened on October 3, 2023 when Loop Capital changed their price target from $62 to $53 for Ingevity Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ingevity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ingevity was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.
While ratings are subjective and will change, the latest Ingevity (NGVT) rating was a maintained with a price target of $55.00 to $45.00. The current price Ingevity (NGVT) is trading at is $44.44, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.